Development of complement-fixing 19S, anti-heart mitochondria autoantibody, following myocardial infarction in dogs.
D000818:Animals; D000941:Antigens / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000097:blood; D001323:Autoantibodies / Q000032:analysis*; D002499:Centrifugation, Density Gradient; D003168:Complement Fixation Tests; D003331:Coronary Vessels / Q000601:surgery; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects; D007075:Immunoglobulin M / Q000032:analysis*; D008012:Lidocaine / Q000494:pharmacology; D008026:Ligation; D008931:Mitochondria, Muscle / Q000276:immunology*; D009203:Myocardial Infarction / Q000175:diagnosis / Q000201:enzymology / Q000209:etiology / Q000276:immunology* / Q000503:physiopathology; D009206:Myocardium / Q000276:immunology*; D012116:Resins, Plant; D013347:Subcellular Fractions / Q000276:immunology
D000941:Antigens; D001323:Autoantibodies; D007075:Immunoglobulin M; D012116:Resins, Plant; D008012:Lidocaine; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase